FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/091424 [Registered on: 22/07/2025] Trial Registered Prospectively
Last Modified On: 22/07/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparing Dexmedetomidine with lignocaine to check post-extubation cough reflex 
Scientific Title of Study   Supra and subglottic instillation of dexmedetomidine for prevention of coughing during emergence from general anaesthesia : A comparison with lignocaine .  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DR HARSHA 
Designation  Junior Resident 
Affiliation  INDIRA GANDHI INSTITUTE OF MEDICAL SCIENCES 
Address  Ward Block 13, NEAR Neuro OT Complex, First floor, Department of Anaesthesiology, Indira Gandhi Institute Of Medical Sciences, , Sheikhpura, Patna, Bihar, India
Indira Gandhi Institute Of Medical Sciences, Department of Anaesthesiology, Sheikhpura, Patna, Bihar, India
Patna
BIHAR
800014
India 
Phone  8986631508  
Fax    
Email  harshay029@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR Mumtaz Hussain 
Designation  Professor 
Affiliation  INDIRA GANDHI INSTITUTE OF MEDICAL SCIENCES 
Address  Ward Block 13, Near Neuro OT complex, Department of Anaesthesiology, Indira Gandhi Institute Of Medical Sciences, Sheikhpura, Patna, Bihar, India
Indira Gandhi Institute Of Medical Sciences, Department of Anaesthesiology, Sheikhpura, Patna, Bihar, India
Patna
BIHAR
800014
India 
Phone  9973152076  
Fax    
Email  drhussain72@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  DR HARSHA 
Designation  Junior Resident 
Affiliation  INDIRA GANDHI INSTITUTE OF MEDICAL SCIENCES 
Address  Ward Block 13, Near Neuro OT Complex, Department of Anaesthesiology, Indira Gandhi Institute Of Medical Sciences, Sheikhpura, Patna
Indira Gandhi Institute Of Medical Sciences, Department of Anaesthesiology, Sheikhpura, Patna, Bihar, India
Patna
BIHAR
800014
India 
Phone  8986631508  
Fax    
Email  harshay029@gmail.com  
 
Source of Monetary or Material Support  
SELF, Dr. Harsha, Junior Resident, Department of Anesthesiology, Ward Block 13, First Floor, Indira Gandhi Institute of Medical Sciences, Patna, Bihar India. Pin code 800014 
 
Primary Sponsor  
Name  DR HARSHA 
Address  Ward Block 13, first Floor, Near Neuro Ot Complex, Department of Anesthesiology, Indira Gandhi Institute Of Medical Sciences, Department of Anaesthesiology, Sheikhpura, Patna, Bihar, India Pin Code 800014 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Harsha  Indira Gandhi Institute of Medical Sciences  Ward Block 13, First Floor, Neuro OT (1-12) complex, Department of Anesthesiology,
Patna
BIHAR 
8986631508

harshay029@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics committee, IGIMS  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Dexmedetomidine Group  Dexmedetomidine at a dose of 0.5 mcg/kg of body weight via the subglottic port of the TuoRen Supra/subglottic Injectable endotracheal tube Duration - 15 minutes Extubation Time 
Intervention  Lignocaine Group  2% Lignocaine at a dose of 1.5mg/kg of body weight via the subglottic port of the TuoRen Supra/subglottic Injectable endotracheal tube Duration - 15 minutes before Extubation Time 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1. Consent for participation
2. Scheduled for elective surgery under genaral anaesthsia 
 
ExclusionCriteria 
Details  Refusal of Patient.
2. With Known contraindication and sensitivity of study drugs
3. History of asthma or COPD
4. Who requires post op ventilation
5. Anticipated difficult airway
6. history of tracheal surgery 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
To assess the incidence and severity of coughing during emergence from general anesthesia  Time POINT - JUST AFTER EXTUBATION, 1min post extubation, 2 min post extubation, 3 min post extubation, 4 min post extubation, 5 min post extubation 
 
Secondary Outcome  
Outcome  TimePoints 
1. Extubation Time
2. Hemodynamic Parameters
3. Surgeon satisfaction
4. Adverse Effects 
1. During Extubation
2. 1 min post extubation
3. 2 min post extubation
4. 3 min post extubation
5. 4 min post extubation
6. 5 min post extubation 
 
Target Sample Size   Total Sample Size="170"
Sample Size from India="170" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   01/09/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

So far no study has detected the  local action of dexmedetomidine on tracheal mucosa in patients undergoing endotracheal intubation. Therefore we hypothesize that direct instillation of dexmedetomidine via supra/subglottic injectable endotracheal tube port could suppress cough reflex following tracheal extubation.

This prospective, randomized, double blinded trial will compare the safety and efficacy of direct instillation of tracheal mucosa by dexmedetomidine and lidocaine via a supra or subglottic injectable endotracheal port for smooth tracheal extubation in patients undergoing general surgery.

 
Close